Trump's Hair Drug Finasteride Missing from Medical Records Sparks Debate
Trump's Hair Drug Finasteride Missing from Medical Records

The internet has long been fascinated by US President Donald Trump's distinctive hair, spawning countless memes and jokes. For years, his secret weapon against baldness was finasteride, a common medication for male-pattern hair loss. However, according to a recent report by The Washington Post, this drug has disappeared from the president's official medical records, raising questions about transparency and health.

The Disappearance of Finasteride from Trump's Records

Finasteride, sold under the brand name Propecia, was first mentioned in Trump's health records in 2017 by his then-physician Harold Bornstein. It remained listed throughout his first term. However, since his second inauguration, including a recent check-up at Walter Reed, the drug has not been included in any public medical reports. The latest report, released last week, only lists rosuvastatin and ezetimibe for cholesterol, along with aspirin for heart health. Trump's physician, Sean Barbabella, declared the president to be in excellent physical health, but the omission of finasteride has sparked concern among experts.

Robert Klitzman, a psychiatrist at Columbia University, told The Washington Post that this raises significant questions about what else might not be revealed, noting that finasteride has been linked to an increased risk of depression. The White House has not clarified whether Trump still takes the drug, stating that disclosed reports only include medications considered clinically relevant at the time. This leaves several possibilities: Trump may have stopped taking finasteride, it may no longer be deemed important for public disclosure, or it may be viewed as non-essential information.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

How Finasteride Works

Finasteride works by blocking the conversion of testosterone into dihydrotestosterone (DHT), the hormone responsible for hair loss. Lower DHT levels slow baldness and can even promote hair regrowth. Approved by the US Food and Drug Administration in the 1990s, it remains one of the few proven treatments for male-pattern baldness. However, its use comes with potential side effects, including sexual health issues such as reduced libido, erectile dysfunction, and decreased semen volume. In some cases, these effects persist after discontinuation. Mental health concerns, including depression, anxiety, insomnia, brain fog, and suicidal thoughts, have also been reported, though the exact connection remains debated.

The Broader Issue of Presidential Transparency

This controversy is not just about hair; it touches on the transparency and accountability expected from leaders. Presidential health has always been a sensitive topic, with debates during both the Trump and Biden administrations. Critics argue that the omission of finasteride could be an attempt to hide more serious health concerns under the guise of privacy. The public expects leaders to be forthcoming about their health, given their responsibility for making sound decisions. Trump's health records have drawn scrutiny for years, from glowing doctor statements to missing details about hospital visits.

Ultimately, the finasteride controversy underscores a larger question: how much should the public know about those in charge? While privacy is important, the need for transparency in matters that could affect governance remains paramount.

Pickt after-article banner — collaborative shopping lists app with family illustration